SCHEDULE: Pentwater Capital Discloses 8.5% Stake in Core Scientific

Pentwater Capital Management LP and Matthew Halbower have reported a passive 8.5% beneficial ownership stake in Core Scientific, Inc., totaling 26,050,000 shares.

Summary

• Pentwater Capital Management LP and Matthew Halbower (Reporting Persons) have filed a Schedule 13G for Core Scientific, Inc.
• They collectively beneficially own 26,050,000 shares of Common Stock.
• This represents an 8.5% stake in Core Scientific, Inc.
• The ownership includes 1,800,000 shares of Common Stock issuable upon the exercise of options.
• The percentage is calculated based on 307,355,193 shares of Common Stock outstanding as of September 19, 2025, as reported in the Company's Definitive Proxy Statement.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: The filing is a neutral, factual disclosure of a significant passive ownership stake. The presence of a major institutional investor can be seen as a mild positive, but it provides no operational or financial performance details to warrant a higher score.

Positives

• A significant institutional investor, Pentwater Capital Management, holds a substantial 8.5% stake, potentially signaling confidence in Core Scientific.
• The filing indicates a passive investment, suggesting no immediate intent to influence control, which can provide stability to the company's current management and strategic direction.

Risks

• The filing explicitly states that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer. This means the significant stake may not translate into active shareholder advocacy if the company faces operational challenges requiring intervention.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding Core Scientific's future performance or strategic direction.

Industry Context

This filing reflects a significant passive investment by a major hedge fund in Core Scientific, a prominent player in the Bitcoin mining industry. Such institutional interest can be viewed positively within the digital asset sector, which often sees fluctuating investor sentiment and a need for stable, long-term capital commitments.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake by Pentwater Capital Management could influence investor perception and potentially share price, signaling confidence from a major fund.
• Management: Awareness of a large passive shareholder may influence strategic decisions, though the filing explicitly states no intent to influence control.

Key Dates

Recommendation

This Schedule 13G filing primarily serves as a disclosure of a significant passive ownership stake by Pentwater Capital Management LP and Matthew Halbower in Core Scientific, Inc. While the presence of a major institutional investor holding an 8.5% stake can be viewed as a positive signal of confidence, the filing itself does not provide sufficient operational, financial, or strategic details to warrant a 'buy' or 'sell' recommendation. It indicates a long-term, passive investment approach. Investors should 'hold' and await further company-specific performance reports or strategic updates to make a more informed decision, while acknowledging the institutional backing.

Keywords

Core Scientific, Pentwater Capital Management, Matthew Halbower, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Passive Investment, Bitcoin Mining